Story perspectives

Jamison Boosts Abbott Stake; Q4 Earnings Beat Expectations

1/27/2025

42 6

Summary

Story summary

Jamison Private Wealth Management boosted its Abbott Laboratories (NYSE:ABT) stake by 27%, now holding 16,084 shares valued at $1.82 million.
SG Americas Securities reduced its position by 89.6%, retaining 33,695 shares worth $3.81 million.
Institutional investors control 75.18% of Abbott's stock.
Abbott's Q4 earnings reached $1.34 per share, with revenue at $10.97 billion.
The company increased its quarterly dividend to $0.59 per share, effective February 14.

History

Historical Context

Abbott Laboratories' recent financial maneuvers echo its 2011 split into AbbVie, a strategic move to enhance focus and shareholder value. This historical precedent illustrates how companies adapt to market pressures, a trend seen with other firms like Johnson & Johnson, which also restructured to sharpen operational efficiency.

1 of 2

Story summary

Jamison Private Wealth Management boosted its Abbott Laboratories (NYSE:ABT) stake by 27%, now holding 16,084 shares valued at $1.82 million.
SG Americas Securities reduced its position by 89.6%, retaining 33,695 shares worth $3.81 million.
Institutional investors control 75.18% of Abbott's stock.
Abbott's Q4 earnings reached $1.34 per share, with revenue at $10.97 billion.
The company increased its quarterly dividend to $0.59 per share, effective February 14.

1 / 2